TG Therapeutics (TGTX) Reports Q3 Loss of $0.43

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. VRTX
4. CHKP
5. CRWD
6. ON
7. HNGE
8. INSP
9. MTCH
10. CVI

Go back to TG Therapeutics (TGTX) Reports Q3 Loss of $0.43

TG Therapeutics, Inc. Provides Business Update and Reports Third Quarter 2018 Financial Results

November 9, 2018 7:30 AM EST

Investor Conference Call to be Held Today, Friday, November 9, 2018 at 8:30 AM ET  

NEW YORK, Nov. 09, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its financial results for the third quarter ended September 30, 2018 and recent company developments.

Michael S. Weiss, the Company's Executive Chairman and Chief Executive Officer, stated, "We are pleased by the progress made in the third quarter of 2018, most notably the completion of full enrollment in the current cohorts of the UNITY-NHL trial, as well as in the ULTIMATE Phase 3 program in MS. We now have... More